Release
📈 Stocks
NervGen Appoints Sam Jackson as Chief Medical Officer to Lead RESTORE Study
(just now)
NervGen Pharma Corp. names industry veteran Sam Jackson as Chief Medical Officer to spearhead the Phase 3 RESTORE study and advance its…